Cargando…

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland

BACKGROUND: HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross-resistance among representatives of this class of antiretrovirals. The aim of this study was to analyse integrase sequence variability among antiretroviral treatment naive and experienced patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parczewski, Miłosz, Bander, Dorota, Urbańska, Anna, Boroń-Kaczmarska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547692/ https://www.ncbi.nlm.nih.gov/pubmed/23259737 http://dx.doi.org/10.1186/1471-2334-12-368

Ejemplares similares

HIV-1 Subtype D Infections among Caucasians from Northwestern Poland—Phylogenetic and Clinical Analysis
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

Temporal increase in HIV-1 non-R5 tropism frequency among antiretroviral-naive patients from northern Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Δ32 Deletion
por: Parczewski, Milosz, et al.
Publicado: (2011)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

Transmitted HIV drug resistance and subtype patterns among blood donors in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2021)

Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland
por: Serwin, Karol, et al.
Publicado: (2021)

Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2015)

CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
por: Parczewski, M, et al.
Publicado: (2010)

Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2016)

The temporal increase in HIV-1 non-R5 tropism frequency among newly diagnosed patients from northern Poland is associated with clustered transmissions
por: Parczewski, Miłosz, et al.
Publicado: (2015)

Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
por: Mandikiyana Chirimuta, Linda A., et al.
Publicado: (2022)

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
por: Doyle, Tomas, et al.
Publicado: (2015)

Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study
por: Underwood, Mark, et al.
Publicado: (2022)

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy
por: Fernandes, Sara Rodrigues, et al.
Publicado: (2023)

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV
por: Muccini, Camilla, et al.
Publicado: (2023)

Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021)

Correction: Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
por: Lan, Yun, et al.
Publicado: (2020)

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa
por: Gottlieb, Geoffrey S., et al.
Publicado: (2011)

Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
por: Serwin, Karol, et al.
Publicado: (2021)

Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2017)

HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naïve Patients after the Implementation of Antiretroviral Therapy in Ghana
por: Nii-Trebi, Nicholas I., et al.
Publicado: (2013)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
por: Yu, Fengting, et al.
Publicado: (2022)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

A National HIV Provider Survey of Antiretroviral Therapy Preferences for Management of Treatment-Naive and Experienced Individuals With Drug Resistance
por: Krishnan, Sonya, et al.
Publicado: (2023)

Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study
por: Kim, Yeonjae, et al.
Publicado: (2018)

Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China
por: Lai, Jinglan, et al.
Publicado: (2021)

Weight and Metabolic Outcomes in Naïve HIV Patients Treated with Integrase Inhibitor-Based Antiretroviral Therapy: A Systematic Review and Meta-Analysis
por: Valenzuela-Rodriguez, German, et al.
Publicado: (2023)

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
por: Katlama, Christine, et al.
Publicado: (2009)

HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study
por: Orta-Resendiz, Aurelio, et al.
Publicado: (2020)

The use of integrase inhibitors in treatment-experienced patients
por: Gatell, Jose M
Publicado: (2009)

Transmitted Drug Resistance Against Integrase Strand Transfer Inhibitors in Iranian HIV-Infected Naïve Patients
por: Hashempour, Ava, et al.
Publicado: (2023)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure
por: van Hal, Sebastiaan J, et al.
Publicado: (2009)

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
por: Budambula, Valentine, et al.
Publicado: (2015)

HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes
por: Mendoza, Yaxelis, et al.
Publicado: (2016)

1580. A national prospective HIV provider survey of antiretroviral therapy preferences for management of treatment naïve and experienced individuals with genotypic resistance
por: Krishnan, Sonya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_smhudh09tq9ccecbgf5jk2jts7